A preferred equity remedy is only worth what an intercreditor agreement lets it be worth
This is a structure worth studying closely, because the coupon on paper and the remedy in practice can be two different things entirely. Say an investor takes preferred equity in an adaptive reuse deal, 11 percent current, 4 percent accrued, one asset, a nine story office building converting to 132 units in a secondary Sun Belt CBD. A $4.1m pref tranche sits behind a $52m construction loan. Cash flows on schedule for eleven months. Then the job runs long, say seven months, mostly permits and a mechanical redesign after undersized riser cores turn up for residential fixture counts. Current pay switches off and starts accruing under a clause that reads temporary but isn't. The real risk sits in the remedies themselves. A payment default typically bumps the accrued rate, say to 16 percent, and gives a right to remove the manager. Both are commonly subject to an intercreditor agreement with the senior lender, one that standstills the pref for as long as the senior loan stays in balance. A sponsor's guarantor funding an equity cure, say $3.9m, can keep the senior in balance while the sponsor sits in default to the pref holder at the same time. The pref's only lever freezes exactly when it's needed. Eighteen months later a recap with a new institutional partner can pay the senior down and restructure the equity, offering the pref a choice: take a discount, say 62 cents on the dollar of face plus accrued, or convert into a subordinate common position behind a new preferred return the pref holder doesn't control. Most tranches take the discount, because nobody wants to be last dollar in a building that has already surprised everyone twice. On $300k of face plus roughly $71k accrued, that's about $230k back. An 11 percent current position can turn into a negative return over four years in a deal where the building still gets built and leases up fine. The lesson is to read the intercreditor agreement before the pref term sheet, price the pref off what the remedies are actually worth during a senior standstill rather than off the coupon, and push for a recap consent threshold that requires more than a majority of a tranche the pref holder doesn't control.